TY  - RPRT
TI  - Network pharmacology exploration reveals the bioactive compounds and molecular mechanisms of Li-Ru-Kang against hyperplasia of mammary gland.
AU  - Shizhang Wei
AU  - Xuelin Zhou
AU  - Ming Niu
AU  - Haizhu Zhang
AU  - Xiaoyi Liu
AU  - Ruilin Wang
AU  - Pengyan Li
AU  - Haotian Li
AU  - Huadan Cai
AU  - Yanling Zhao
PY  - 2019
DO  - 10.1007/s00438-019-01569-5
UR  - https://pubmed.ncbi.nlm.nih.gov/31053932/
ID  - 31053932
ER  -